Therapeutic testosterone administration preserves excitatory synaptic transmission in the hippocampus during autoimmune demyelinating disease

Journal of Neuroscience

Volumn 32, Issue 36, 2012, Pages 12312-12324

  Ziehn, Marina O ^a,b   Avedisian, Andrea A ^b   Dervin, Shannon M ^b   Umeda, Elizabeth A ^b   O'Dell, Thomas J ^b   Voskuhl, Rhonda R ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; ANDROGEN RECEPTOR; ANDROSTANOLONE; MYELIN BASIC PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEURON SPECIFIC NUCLEAR PROTEIN; PLACEBO; POSTSYNAPTIC DENSITY PROTEIN 95; SYNAPSIN I; TESTOSTERONE PROPIONATE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ATROPHY; BRAIN ELECTROPHYSIOLOGY; CELL ACTIVATION; CONTROLLED STUDY; DEMYELINATION; DENDRITE; DISEASE SEVERITY; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; STEREOMETRY; SYNAPTIC TRANSMISSION;

ANIMALS; DRUG IMPLANTS; EXCITATORY POSTSYNAPTIC POTENTIALS; GUANYLATE KINASE; HIPPOCAMPUS; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; POLYRADICULONEUROPATHY; RANDOM ALLOCATION; SYNAPTIC TRANSMISSION; TESTOSTERONE;

EID: 84865802390     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2796-12.2012     Document Type: Article

References (69)

1. Amato MP, Portaccio E, Goretti B, Zipoli V, Hakiki B, Giannini M, Pastò (2010) Cognitive impairment in early stages of multiple sclerosis. Neurol Sci 31 [Suppl 2]:S211-S214.
2. Anderson VM, Fisniku LK, Khaleeli Z, Summers MM, Penny SA, Altmann DR, Thompson AJ, Ron MA, Miller DH (2010) Hippocampal atrophy in relapsing-remitting and primary progressive MS: a comparative study. Mult Scler 16: 1083-1090.
3. Arezzo JC, Litwak MS, Zotova EG (2011) Correlation and dissociation of electrophysiology and histopathology in the assessment of toxic neuropathy. Toxicol Pathol 39:46-51.
4. Aubert S, Wendling F, Regis J, McGonigal A, Figarella-Branger D, Peragut JC, Girard N, Chauvel P, Bartolomei F (2009) Local and remote epileptogenicity in focal cortical dysplasias and neurodevelopmental tumours. Brain 132:3072-3086.
5. Barreto G, Veiga S, Azcoitia I, Garcia-Segura LM, Garcia-Ovejero D (2007) Testosterone decreases reactive astroglia and reactive microglia after brain injury in male rates: role of its metabolites, oestrodial and dihydrotestosterone. Eur J Neurosci 25:3039-3046.
6. Bebo BF Jr, Fyfe-Johnson A, Adlard K, Beam AG, Vandenbark AA, Offner H(2001) Low-dose estrogen therapy ameliorates experimental autoim-mune encephalomyelitis in two difference inbred mouse strains. J Immunol 166:2080-2089.
7. Béïque JC, Lin DT, Kang MG, Aizawa H, Takamiya K, Huganir RL (2006) Synapse-specific regulation of AMPA receptor function by PSD-95. Proc Natl Acad Sci U S A 103:19535-19540.
8. Benedict RH, Cookfair D, Gavett R, Gunther M, Munschauer F, Garg N, Weinstock-Guttman B (2006) Validity of the minimal assessment of cognitive function in multiple sclerosis (MCFIMS). J Int Neuropsychol Soc 12:549-558.
9. Benedict RH, Ramasamy D, Munschauer F, Weinstock-Guttman B, Zivadi-nov R (2009) Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy. J Neurol Neurosurg Psychiatry 80:201-206.
10. Brodie AM (1979) Recent advances in studies on estrogen biosynthesis. J Endocrinol Invest 2:445-460.
11. Carlisle HJ, Fink AE, Grant SG, O'Dell TJ (2008) Opposing effects of PSD-93 and PSD-95 on long-term potentiation and spike timing-dependent plasticity. J Physiol 586:5885-5900.
12. Centonze D, Muzio L, Rossi S, Cavasinni F, De Chiara V, Bergami A, (2009) Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis. J Neurosci 29:3442-3452.
13. Chiaravalloti ND, DeLuca J (2008) Cognitive impairment in multiple sclerosis. Lancet Neurol 7:1139-1151.
14. Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T (1998) Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. New Eng J Med 339:285-291.
15. Cooke BM, Woolley CS (2005) Gonadal hormone modulation of dendrites in the mammalian CNS. J Neurobiol 64:34-46.
16. Crawford DK, Mangiardi M, Song B, Patel R, Du S, Sofroniew MV, Voskuhl RR, Tiwari-Woodruff SK (2010) Oestrogen receptor beta ligand: a novel treatment to enhance endogenous functional remyelination. Brain 133:2999-3016.
17. Cruz-Orive LM (1999) Precision of Cavalieri sections and slices with local errors. J Microsc 193:182-198.
18. Cull-Candy SG, Leszkiewicz DN (2004) Role of distinct NMDA receptor subtypes at central synapses. Sci STKE 255:re16.
19. Cuthbert PC, Stanford LE, Coba MP, Ainge JA, Fink AE, Opazo P, Delgado JY, Komiyama NH, O'Dell TJ, Grant SG (2007) Synapse-associated protein 102/dlgh3 couples the NMDA receptor to specific plasticity pathways and learning strategies. J Neurosci 27:2673-2682.
20. Driscoll I, Resnick SM (2007) Testosterone and cognition in normal aging and Alzheimer's disease: an update. Curr Alzheimer Res 4:33-45.
21. Du S, Sandoval F, Trinh P, Umeda E, Voskuhl R (2011) Estrogen receptor-beta ligand treatment modulates dendritic cells in the target organ during autoimmune demyelinating disease. Eur J Immunol 41:140-150.
22. Dutta R, Chang A, Doud MK, Kidd GJ, Ribaudo MV, Young EA, Fox RJ, Staugaitis SM, Trapp BD (2011) Demyelination causes synaptic altera-tions in hippocampi from Multiple Sclerosis patients. Ann Neurol 69:445-454.
23. Ehrlich I, Malinow R (2004) Postsynaptic density 95 controls AMPA recep-tor incorporation during long-term potentiation and experience-driven plasticity. J Neurosci 24:916-927.
24. Elias GM, Funke L, Stein V, Grant SG, Bredt DS, Nicoll RA (2006) Synapse-specific and developmentally regulated targeting of AMPA receptors by a family of MAGUK scaffolding proteins. Neuron 52:307-320.
25. Elias GM, Nicoll RA (2007) Synaptic trafficking of glutamate receptor by MAGUK scaffolding proteins. Trends Cell Biol 17:343-352.
26. Fargo KN, Sengelaub DR (2007) Androgenic, but not estrogenic, protection of motoneurons from somal and dendritic atrophy induced by the death of neighboring motoneurons. Dev Neurobiol 67:1094-1106.
27. Frye CA, Edinger KL, Seliga AM, Wawrzycki JM (2004) 5alpha-reduced androgens may have actions in the hippocampus to enhance cognitive per-formance of male rats. Psychoneuroendocrinology 29:1019-1027.
28. Galea LA, Uban KA, Epp JR, Brummelte S, Barha CK, Wilson WL, Lieblich SE, Pawluski JL (2008) Endocrine regulation of cognition and neuro-plasticity: our pursuit to unveil the complex interaction between hor-mones, the brain, and behaviour. Can J Exp Psychol 62:247-260.
29. Geurts JJ, Bö L, Roosendaal SD, Hazes T, Daniëls R, Barkhof F, Witter MP, Huitinga I, van der Valk P (2007) Extensive hippocampal demyelination in multiple sclerosis. J Neuropathol Exp Neurol 66:819-827.
30. Gold SM, Voskuhl RR (2009) Estrogen and testosterone therapies in multiple sclerosis. Prog Brain Res 175:239-251.
31. Gold SM, Chalifoux S, Giesser BS, Voskuhl RR (2008) Immune modulation and increased neurotrophic factor production in multiple sclerosis patients treated with testosterone. J Neuroinflammation 5:32.
32. Gundersen HJ, Jensen EB (1987) The efficiency of systematic sampling in stereology and its prediction. J Microsc 147:229-263.
33. Hanak SE, Reilly EM, Wotanis J, Zhu B, Pulicicchio C, McMonagle-Strucko K, Wettstein JG, Black MD (2004) An electrophysiological model of spinal transmission deficits in experimental autoimmune encephalomyelitis. J Pharmacol Exp Ther 308:214-220.
34. Ito A, Bebo BF Jr, Matejuk A, Zamora A, Silverman M, Fyfe-Johnson A, Offner H (2001) Estrogen treatment down-regulates TNF-alpha production and reduces the severity of experimental autoimmune encepha-lomyelitis in cytokine knockout mice. J Immunol 167:542-552.
35. Kim E, Sheng M (2004) PDZ domain proteins of synapses. Nat Rev Neurosci 5:771-781.
36. Kim S, Liva SM, Dalal MA, Verity MA, Voskuhl RR (1999) Estriol amelio-rates autoimmune demyelinating disease: implications for multiple sclerosis. Neurology 52:1230-1238.
37. Komiyama NH, Watabe AM, Carlisle HJ, Porter K, Charlesworth P, Monti J, Strathdee DJ, O'Carroll CM, Martin SJ, Morris RG, O'Dell TJ, Grant SG (2002) SynGAP regulates ERK/MAPK signaling, synaptic plasticity, and learning in the complex with postsynaptic density 95 and NMDA recep-tor. J Neurosci 22:9721-9732.
38. Kuzumaki N, Ikegami D, Imai S, Narita M, Tamura R, Yajima M, (2010) Enhanced IL-1beta production in response to the activation of hippocampal glial cells impairs neurogenesis in aged mice. Synapse 64:721-728.
39. Lehmann HC, Zhang J, Mori S, Sheikh KA (2010) Diffusion tensor im-aging to assess axonal regeneration in peripheral nerves. Exp Neurol 223:238-244.
40. Liu HB, Loo KK, Palaszynski K, Ashouri J, Lubahn DB, Voskuhl RR (2003) Estrogen receptor alpha mediates estrogen's immune protection in autoimmune disease. J Immunol 171:6936-6940.
41. Liu HY, Buenafe AC, Matejuk A, Ito A, Zamora A, Dwyer J, Vandenbark AA, Offner H (2002) Estrogen inhibition of EAE involves effects on dendritic cell function. J Neurosci Res 70:238-248.
42. MacKenzie-Graham A, Tiwari-Woodruff SK, Sharma G, Aguilar C, Vo KT, Strickland LV (2009) Purkinje cell loss in experimental autoimmune encephalomyelitis. Neuroimage 48:637-651.
43. MacLusky NJ, Hajszan T, Prange-Kiel J, Leranth C (2006) Androgen mod-ulation of hippocampal synaptic plasticity. Neuroscience 138:957-965.
44. Matejuk A, Hopke C, Vandenbark AA, Hurn PD, Offner H (2005) Middle-age male mice have increased severity of experimental autoimmune en-cephalomyelitis and are unresponsive to testosterone therapy. J Immunol 174:2387-2395.
45. Morales LB, Loo KK, Liu HB, Peterson C, Tiwari-Woodruff S, Voskuhl RR (2006) Treatment with an estrogen receptor {alpha} ligand is neuroprotective in experimental autoimmune encephalomyelitis. J Neurosci 26:6823-6833.
46. Palaszynski KM, Loo KK, Ashouri JF, Liu HB, Voskuhl RR (2004) Andro-gens are protective in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. J Neuroimmunol 146:144-152.
47. Papadopoulos D, Dukes S, Patel R, Nicholas R, Vora A, Reynolds R (2009) Substantial archaeocortical atrophy and neuronal loss in multiple sclero-sis. Brain Pathol 19:238-253.
48. Paxinos G, Franklin KBJ (2001) The Mouse brain in stereological coordinates, Ed 2. San Diego: Academic.
49. Pettinelli CB, McFarlin DE (1981) Adoptive transfer of experimental aller-gic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 12-T lymphocytes. J Immunol 127:1420-1423.
50. Pickering M, O'Connor JJ (2007) Pro-inflammatory cytokines and their ef-fects in the dentate gyrus. Prog Brain Res 163:339-354.
51. Polanczyk M, Zamora A, Subramanian S, Matejuk A, Hess DL, Blankenhorn EP, Teuscher C, Vandenbark AA, Offner H (2003) The protective effect of 17beta-estradiol on experimental autoimmune encephalomyelitis is mediated through estrogen receptor-alpha. Am J Pathol 163:1599-1605.
52. Rasmussen S, Wang Y, Kivisäkk P (2007) Persistent activation of microglia is associated with neuronal dysfunction of callosal projecting pathways and multiple sclerosis-like lesions in relapsing remitting experimental autoimmune encephalomyelitis. Brain 130:2816-2829.
53. Roosendaal SD, Moraal B, Vrenken H, Castelijns JA, Pouwels PJ, Barkhof F, Geurts JJ (2008) In vivo imaging of hippocampal lesions in multiple sclerosis. J Magn Reson Imaging 27:726-731.
54. Rumbaugh G, Vicini S (1999) Distinct synaptic and extrasynaptic NMDA receptors in developing cerebellar granule cell neurons. J Neurosci 19:10603-10610.
55. Schafer DP, Stevens B (2010) Synapse elimination during development and disease: immune molecules take centre stage. Biochem Soc Trans 38:476-481.
56. Sicotte NL, Liva SM, Klutch R, Pfeiffer P, Bouvier S, Odesa S, Wu TC, Voskuhl RR (2002) Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann Neurol 52:421-428.
57. Sicotte NL, Giesser BS, Tandon V, Klutch R, Steiner B, Drain AE (2007) Testosterone treatment in multiple sclerosis: a pilot study. Arch Neurol 64:683-688.
58. Sicotte NL, Kern KC, Giesser BS, Arshanapalli A, Schultz A, Montag M, Wang H, Bookheimer SY (2008) Regional hippocampal atrophy in multiple sclerosis. Brain 131:1134-1141.
59. Simerly RB, Chang C, Muramatsu M, Swanson LW (1990) Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study. J Comp Neurol 294:76-95.
60. Spence RD, Hamby ME, Umeda E, Itoh N, Du S, Wisdom AJ, Cao Y, Bondar G, Lam J, Ao Y, Sandoval F, Suriany S, Sofroniew MV, Voskuhl RR (2011) Neuroprotection mediated through estrogen receptor-alpha in astrocytes. Proc Natl Acad Sci U S A 108:8867-8872.
61. Subramanian S, Matejuk A, Zamora A, Vandenbark AA, Offner H (2003) Oral feeding with ethinyl estradiol suppresses and treats experimental autoimmune encephalomyelitis in SJL mice and inhibits the recruitment of inflam-matory cells into the central nervous system. J Immunol 170:1548-1555.
62. Thornton AE, Raz N (1997) Memory impairment in multiple sclerosis. Neuropsychology 11:357-366.
63. Tiwari-Woodruff S, Morales LB, Lee R, Voskuhl RR (2007) Differential neuro-protective and anti-inflammatory effects of estrogen receptor (ER) and ER ligand treatment. Proc Natl Acad Sci U S A 104:14813-14818.
64. Trapp BD, Wujek JR, Criste GA, Jalabi W, Yin X, Kidd GJ, Stohlman S, Ransohoff R (2007) Evidence for synaptic stripping by cortical micro-glia. Glia 55:360-368.
65. Voskuhl RR, Peterson RS, Song B, Ao Y, Morales LB, Tiwari-Woodruff S, Sofroniew MV (2009) Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS. J Neurosci 29:11511-11522.
66. Wiltgen BJ, Royle GA, Gray EE, Abdipranoto A, Thangthaeng N, Jacobs N, Saab F, Tonegawa S, Heinemann SF, O'Dell TJ, Fanselow MS, Vissel B (2010) A role for calcium-permeable AMPA receptors in synaptic plas-ticity and learning. PLoS One pii:e12818.
67. Young WJ, Chang C (1998) Ontogeny and autoregulation of androgen re-ceptor mRNA expression in the nervous system. Endocrine 9:79-88.
68. Ziehn MO, Avedisian AA, Tiwari-Woodruff S, Voskuhl RR (2010) Hippocampal CA1 atrophy and synaptic loss during experimental autoim-mune encephalomyelitis, EAE. Lab Invest 90:774-786.
69. Ziehn MO, Avedisan AA, Dervin SD, O'Dell TJ, Voskuhl RR (2012) Estriol preserves synaptic transmission in the hippocampus during autoimmune demyelinating disease. Lab Invest 92:1234-1245.